IL102503A - History of Alkanamine of 6-Oxoazepino] CD-5,4,3 [Indole, their preparation and pharmaceutical preparations containing them - Google Patents
History of Alkanamine of 6-Oxoazepino] CD-5,4,3 [Indole, their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL102503A IL102503A IL10250392A IL10250392A IL102503A IL 102503 A IL102503 A IL 102503A IL 10250392 A IL10250392 A IL 10250392A IL 10250392 A IL10250392 A IL 10250392A IL 102503 A IL102503 A IL 102503A
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- group
- lower alkyl
- general formula
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4125292A DE4125292A1 (de) | 1991-07-31 | 1991-07-31 | 6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL102503A0 IL102503A0 (en) | 1993-01-14 |
| IL102503A true IL102503A (en) | 1995-12-31 |
Family
ID=6437366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10250392A IL102503A (en) | 1991-07-31 | 1992-07-15 | History of Alkanamine of 6-Oxoazepino] CD-5,4,3 [Indole, their preparation and pharmaceutical preparations containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5272143A (no) |
| EP (1) | EP0525584B1 (no) |
| JP (1) | JP3174158B2 (no) |
| KR (1) | KR930002353A (no) |
| CN (2) | CN1069733A (no) |
| AT (1) | ATE161012T1 (no) |
| AU (1) | AU649153B2 (no) |
| CA (1) | CA2075102A1 (no) |
| CZ (1) | CZ239392A3 (no) |
| DE (2) | DE4125292A1 (no) |
| ES (1) | ES2110454T3 (no) |
| FI (1) | FI923440A (no) |
| HU (2) | HU211105B (no) |
| IE (1) | IE922310A1 (no) |
| IL (1) | IL102503A (no) |
| MX (1) | MX9204457A (no) |
| NO (1) | NO300375B1 (no) |
| NZ (1) | NZ243715A (no) |
| RU (1) | RU2078765C1 (no) |
| TW (1) | TW207541B (no) |
| ZA (1) | ZA925093B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5414130A (en) * | 1993-12-23 | 1995-05-09 | The Dow Chemical Company | Process for the preparation of diaminoresorcinol |
| EE05006B1 (et) | 1999-01-11 | 2008-04-15 | Agouron Pharmaceuticals, Inc. | Polü(ADP-riboos)polümeraaside tritsüklilised inhibiitorid ja neid sisaldavad farmatseutilised kompositsioonid |
| ECSP003637A (es) | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
| JP5465241B2 (ja) | 2008-05-29 | 2014-04-09 | アルバニー モレキュラー リサーチ， インコーポレイテッド | ５−ｈｔ３受容体調節物質ならびにその作製方法および使用 |
| SG10201406805RA (en) * | 2010-02-12 | 2014-11-27 | Pfizer | Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| US11236103B2 (en) | 2018-07-27 | 2022-02-01 | Biotheryx, Inc. | Bifunctional compounds |
| US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910193A (en) * | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
-
1991
- 1991-07-31 DE DE4125292A patent/DE4125292A1/de not_active Withdrawn
-
1992
- 1992-07-08 ZA ZA925093A patent/ZA925093B/xx unknown
- 1992-07-15 IE IE231092A patent/IE922310A1/en not_active Application Discontinuation
- 1992-07-15 IL IL10250392A patent/IL102503A/en not_active IP Right Cessation
- 1992-07-21 ES ES92112431T patent/ES2110454T3/es not_active Expired - Lifetime
- 1992-07-21 EP EP92112431A patent/EP0525584B1/de not_active Expired - Lifetime
- 1992-07-21 AT AT92112431T patent/ATE161012T1/de not_active IP Right Cessation
- 1992-07-21 DE DE59209055T patent/DE59209055D1/de not_active Expired - Fee Related
- 1992-07-24 NZ NZ243715A patent/NZ243715A/en unknown
- 1992-07-24 HU HU9202430A patent/HU211105B/hu not_active IP Right Cessation
- 1992-07-30 NO NO923004A patent/NO300375B1/no unknown
- 1992-07-30 AU AU20677/92A patent/AU649153B2/en not_active Ceased
- 1992-07-30 RU SU925052604A patent/RU2078765C1/ru active
- 1992-07-30 KR KR1019920013719A patent/KR930002353A/ko not_active Application Discontinuation
- 1992-07-30 CN CN92108977A patent/CN1069733A/zh active Pending
- 1992-07-30 FI FI923440A patent/FI923440A/fi not_active Application Discontinuation
- 1992-07-30 JP JP20377092A patent/JP3174158B2/ja not_active Expired - Fee Related
- 1992-07-30 MX MX9204457A patent/MX9204457A/es not_active IP Right Cessation
- 1992-07-31 CA CA002075102A patent/CA2075102A1/en not_active Abandoned
- 1992-07-31 US US07/922,527 patent/US5272143A/en not_active Expired - Lifetime
- 1992-07-31 CZ CS922393A patent/CZ239392A3/cs unknown
- 1992-09-10 TW TW081107187A patent/TW207541B/zh active
-
1994
- 1994-09-30 HU HU94P/P00032P patent/HU210217A9/hu unknown
-
1996
- 1996-01-19 CN CN96100699A patent/CN1141773A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE4125292A1 (de) | 1993-02-04 |
| HU210217A9 (en) | 1995-02-28 |
| JP3174158B2 (ja) | 2001-06-11 |
| AU649153B2 (en) | 1994-05-12 |
| JPH05202052A (ja) | 1993-08-10 |
| IL102503A0 (en) | 1993-01-14 |
| ATE161012T1 (de) | 1997-12-15 |
| MX9204457A (es) | 1993-05-01 |
| ZA925093B (en) | 1993-04-28 |
| HU211105B (en) | 1995-10-30 |
| NO300375B1 (no) | 1997-05-20 |
| HU9202430D0 (en) | 1992-10-28 |
| CN1069733A (zh) | 1993-03-10 |
| HUT65453A (en) | 1994-06-28 |
| FI923440A (fi) | 1993-02-01 |
| IE922310A1 (en) | 1993-02-10 |
| TW207541B (no) | 1993-06-11 |
| EP0525584B1 (de) | 1997-12-10 |
| CZ239392A3 (en) | 1993-04-14 |
| NO923004L (no) | 1993-02-01 |
| ES2110454T3 (es) | 1998-02-16 |
| NO923004D0 (no) | 1992-07-30 |
| RU2078765C1 (ru) | 1997-05-10 |
| NZ243715A (en) | 1995-03-28 |
| FI923440A0 (fi) | 1992-07-30 |
| DE59209055D1 (de) | 1998-01-22 |
| EP0525584A1 (de) | 1993-02-03 |
| KR930002353A (ko) | 1993-02-23 |
| AU2067792A (en) | 1993-02-04 |
| US5272143A (en) | 1993-12-21 |
| CA2075102A1 (en) | 1993-02-01 |
| CN1141773A (zh) | 1997-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7238690B2 (en) | Substituted heterocycle fused gamma-carbolines | |
| US5571833A (en) | Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists | |
| EP1546099B1 (en) | 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists | |
| DK158942B (da) | 3-(2-(dimethylamino)ethyl)-n-methyl-1h-indol-5-methansulfonamid, farmaceutiske praeparater indeholdende denne forbindelse samt fremgangsmaader til fremstilling af forbindelsen | |
| CA1266482A1 (en) | 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines | |
| IL102503A (en) | History of Alkanamine of 6-Oxoazepino] CD-5,4,3 [Indole, their preparation and pharmaceutical preparations containing them | |
| US20070010568A1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| EP1615634B1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| WO2004056810A1 (en) | Xanthine derivatives as muscarinic receptor antagonists | |
| EP0233413B1 (en) | 3-(2-aminoethyl)indole and -indoline derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| HU224435B1 (hu) | Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények | |
| AU2003274627B2 (en) | A method for preparing indan-1,3-dicarboxylic acid | |
| EP0746556B1 (en) | Tricyclic compounds having affinity for the 5-ht1a receptor | |
| NZ229524A (en) | Condensed diazepinones and pharmaceutical compositions | |
| JPH08225571A (ja) | ６−アルコキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体及びその中間体並びに該化合物を含有する医薬組成物 | |
| JPH08208643A (ja) | ６−メトキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体及びそれを含有する医薬組成物 | |
| KR20050023401A (ko) | 무스카린 수용체 길항제로서 사용가능한 3,6-이치환된아자비시클로 [3.1.0]헥산 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| RH | Patent void |